Perspective gets FDA fast track status for radiopharmaceutical VMT01

seekingalpha09-06

Shares of Perspective Therapeutics (NYSE:CATX) rose 4% in midday trading Thursday after the company said it had received FDA Fast Track Designation for its radiopharmaceutical candidate VMT01 for MC1R...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment